Integrated biomaterials approach that enhances adoptively transferred T cell therapy with cancer vaccine technology provides strong and long-lasting effects against solid tumors
T cell development can be mechanically steered in vitro with engineered tissue-mimicking biomaterials, opening new ways to advance cell manufacturing in adoptive T cell therapies
